• The Daily Trade
  • Posts
  • Market Insights: Strong Earnings from Saratoga & Greenbrier, Jobless Claims at Record Low 📈

Market Insights: Strong Earnings from Saratoga & Greenbrier, Jobless Claims at Record Low 📈

The Daily Trade delivers sharp, daily insights on the US stock market.

Stay informed, spot trends, and trade with confidence.

Fueled for Fortune

Wired's "rocket fuel of AI" label has Wall Street buzzing. Projections skyrocketing to $80 trillion, akin to 41 Amazons, signal a seismic shift. But here's the kicker: astute investors have a shot at riding the wave with a company primed for supremacy. Dive into The Motley Fool's exclusive report for your front-row seat.

Recent Headlines

Saratoga Investment Surprises with Strong Earnings Report (3 minute read)
Saratoga Investment (SAR) reported quarterly earnings of $0.90 per share, surpassing analysts' expectations of $0.82. The company's return on equity stands at 15.88%, and it declared a dividend of $1.09 per share.


Greenbrier Companies Outshines Estimates with Impressive Earnings (4 minute read)
Greenbrier Companies (GBX) announced earnings of $1.72 per share, exceeding the consensus estimate of $1.16. The company also reported revenue of $875.9 million, reflecting an 8.3% year-over-year increase.


Costco's December Sales Surge: A 9.9% Yearly Boost! (3 minute read)
Costco (COST) reported net sales of $27.52 billion for December, marking a 9.9% increase from the previous year. E-commerce sales were particularly strong, contributing to the overall growth.


Hershey's Target Price Takes a Hit: What Analysts Are Saying (4 minute read)
TD Cowen has lowered its target price for Hershey (HSY) from $190 to $172. Despite this downgrade, the stock still shows potential for a 6.49% upside from its previous close.


U.S. Jobless Claims Hit 11-Month Low: What It Means for the Economy (4 minute read)
The number of new unemployment claims fell to 201,000, the lowest in 11 months, indicating a stable labor market. This data could influence the Federal Reserve's decisions on interest rates.


Travelers Stock Gets a Boost: Goldman Sachs Double Upgrade (3 minute read)
Travelers (TRV) received a double upgrade from Goldman Sachs, raising its price target to $278. The upgrade comes as the company navigates challenges from California wildfires.




Technical Analysis Results



Undervalued
BF.B
Brown-Forman Corporation Class B
Volume: 2.2M shares | Price: $35.99

30 Day Performance
30-Day Price History

Technical Indicator Score: 88% Buy
Out of the 8 technical indicators that were used to analyze this stock, 7 indicated buy signals, 1 indicated a neutral signal.
RSI
Buy
MFI
Buy
WillR
Buy
AO
Buy
CCI
Buy
BBANDS
Hold
ULTOSC
Buy
STOCH
Buy

Recent Mentions of BF.B




Undervalued
XP
XP Inc. Class A Common Stock
Volume: 8.6M shares | Price: $11.05

30 Day Performance
30-Day Price History

Technical Indicator Score: 88% Buy
Out of the 8 technical indicators that were used to analyze this stock, 7 indicated buy signals, 1 indicated a neutral signal.
RSI
Buy
MFI
Buy
WillR
Buy
AO
Buy
CCI
Buy
BBANDS
Hold
ULTOSC
Buy
STOCH
Buy

Recent Mentions of XP

XP Inc. (XP): A Bull Case Theory
We came across a bullish thesis on XP Inc. (NASDAQ:XP) on Safe Harbor Stocks’ Substack by Kristopher Rymer. In this article, we will summarize the bulls’ thesis on XP. XP Inc. (NASDAQ:XP)’s share was trading at $11.40 as of Jan 6th. XP’s trailing and forward P/E were 8.84 and 7.33 respectively according to Yahoo Finance. XP is […]

January 2025 US Dividend Stocks To Consider
As the U.S. stock market attempts to rebound from a recent losing streak, with major indices like the Dow Jones and Nasdaq showing early signs of recovery, investors are keenly observing how tech shares are regaining momentum. In this fluctuating environment, dividend stocks can offer stability and income potential, making them an attractive consideration for those seeking to navigate uncertain market conditions.




Overvalued
ANGO
AngioDynamics, Inc.
Volume: 4.4M shares | Price: $12.94

30 Day Performance
30-Day Price History

Technical Indicator Score: 88% Sell
Out of the 8 technical indicators that were used to analyze this stock, 7 indicated sell signals, 1 indicated a neutral signal.
RSI
Sell
MFI
Sell
WillR
Sell
AO
Sell
CCI
Sell
BBANDS
Sell
ULTOSC
Sell
STOCH
Hold

Recent Mentions of ANGO

AngioDynamics (ANGO) Reports Q2 Loss, Tops Revenue Estimates
AngioDynamics (ANGO) delivered earnings and revenue surprises of 63.64% and 2.36%, respectively, for the quarter ended November 2024. Do the numbers hold clues to what lies ahead for the stock?

AngioDynamics: Fiscal Q2 Earnings Snapshot
LATHAM, N.Y. (AP) — AngioDynamics Inc. ANGO) on Wednesday reported a loss of $10.7 million in its fiscal second quarter. On a per-share basis, the Latham, New York-based company said it had a loss of 26 cents.




Undervalued
PEP
PepsiCo, Inc.
Volume: 6.2M shares | Price: $146.54

30 Day Performance
30-Day Price History

Technical Indicator Score: 75% Buy
Out of the 8 technical indicators that were used to analyze this stock, 6 indicated buy signals, 2 indicated neutral signals.
RSI
Buy
MFI
Buy
WillR
Buy
AO
Buy
CCI
Buy
BBANDS
Hold
ULTOSC
Hold
STOCH
Buy

Recent Mentions of PEP

Coca-Cola Vs Pepsi Stock: Which is the Better Buy for 2025?
Let's see which of these iconic beverage makers may be the better investment as we begin 2025.

PepsiCo (PEP) Stock Moves -0.59%: What You Should Know
The latest trading day saw PepsiCo (PEP) settling at $145.40, representing a -0.59% change from its previous close.




Undervalued
CL
Colgate-Palmolive Company
Volume: 4.7M shares | Price: $87.46

30 Day Performance
30-Day Price History

Technical Indicator Score: 75% Buy
Out of the 8 technical indicators that were used to analyze this stock, 6 indicated buy signals, 2 indicated neutral signals.
RSI
Buy
MFI
Buy
WillR
Buy
AO
Buy
CCI
Buy
BBANDS
Buy
ULTOSC
Hold
STOCH
Hold

Recent Mentions of CL

Is Colgate-Palmolive Company (NYSE:CL) the Best January Dividend Stock to Buy?
We recently compiled a list of the 10 Best January Dividend Stocks To Buy. In this article, we are going to take a look at where Colgate-Palmolive Company (NYSE:CL) stands against the other January dividend stocks. In 2024, dividend stocks fell short of investor expectations, largely due to the continuing AI boom and a heightened interest […]

Colgate-Palmolive's (NYSE:CL) investors will be pleased with their respectable 46% return over the last five years
If you buy and hold a stock for many years, you'd hope to be making a profit. Furthermore, you'd generally like to see...




Undervalued
CCI
Crown Castle Inc.
Volume: 3.3M shares | Price: $87.50

30 Day Performance
30-Day Price History

Technical Indicator Score: 75% Buy
Out of the 8 technical indicators that were used to analyze this stock, 6 indicated buy signals, 2 indicated neutral signals.
RSI
Buy
MFI
Buy
WillR
Buy
AO
Buy
CCI
Buy
BBANDS
Hold
ULTOSC
Hold
STOCH
Buy

Recent Mentions of CCI

Terreno Continues Acquisitions, Acquires Maspeth Queens Property
Terreno's recent spate of acquisitions of industrial properties is likely to aid it in banking on solid industrial real estate market tailwinds.

Four Corners Property Trust Hits $265 Million in 2024 Acquisitions
FCPT's latest acquisition marks the culmination of a robust year, bringing the total real estate acquisitions in 2024 to 87 properties.




Check out our partners!

We’ve teamed up with a few like-minded newsletters to bring you even more fresh insights and fun. If you’re craving extra knowledge, entertainment, and/or inspiration in your inbox, give them a look below!

1. Pour Decisions - Your sommelier-approved excuse to open another bottle. Get weekly wine recommendations from top sommeliers across the world.

2. Labrador - Discover high-return real estate deals daily with Labrador— the ultimate bird dog for smart investors.

3. Quip - A daily dose of jokes, trivia, and inspiration to brighten your day.

We want to hear from YOU!

Technical indicator analysis feedback request

Your feedback is important to us. We’re always looking for ways to improve and would love to hear your thoughts on how we can make this newsletter even better for you. Whether you have suggestions, ideas, or just want to share what you enjoy most, we’re all ears.

Simply reply to this email with your thoughts. Every comment helps us serve you better.

Thank you for being a valued reader.

How would you rate today's newsletter?

If there's anything I can do better, please let me know so I can make improvements!

Login or Subscribe to participate in polls.

Let’s stay in touch!

Thank you for reading today’s edition of The Daily Trade.

Let’s connect on LinkedIn!

-Ryan Serkes

Subscribe here if this email was forwarded to you!

Technical Indicator Information

Relative Strength Index (RSI) | Period: 14 days | Overvalued threshold: 70 | Undervalued threshold: 30

Money Flow Index (MFI) | Period: 14 days | Overvalued threshold: 80 | Undervalued threshold: 20

Williams Percent Range (WillR) | Period: 14 days | Overvalued threshold: -20 | Undervalued threshold: -80

Aroon Oscillator (AO) | Period: 14 days | Overvalued threshold: 75 | Undervalued threshold: -75

Moving Average Convergence/Divergence (MACD) | Period: 26/12/9 days | Overvalued threshold: MACD crosses below MACD Signal | Undervalued threshold: MACD crosses above MACD Signal

Stochastic Oscillator (STOCH) | Period: 14/3/3 days | Overvalued threshold: %K crosses below %D above 80 | Undervalued threshold: %K crosses above %D below 20

Commodity Channel Index (CCI) | Period: 20 days | Overvalued threshold: 100 | Undervalued threshold: -100

Bollinger Bands (BBANDS) | Period: 20 days | Overvalued threshold: price >= upper band | Undervalued threshold: price <= lower band

Parabolic Stop and Reverse (SAR) | Period: variable 50 - 100 days | Overvalued threshold: SAR crosses above price | Undervalued threshold: SAR crosses below price

Triple Exponential Average (TRIX) | Period: 15 days | Overvalued threshold: TRIX crosses below 0 | Undervalued threshold: TRIX crosses above 0

Ultimate Oscillator (ULTOSC) | Period: 28/14/7 days | Overvalued threshold: 70 | Undervalued threshold: 30

Directional Movement Index (DMI) | Period: 14 days | Overvalued threshold: PlusDI crosses below MinusDI | Undervalued threshold: PlusDI crosses above MinusDI

Average Directional Index (ADX) | Period: variable 14 days | Requirement: >= 25

Analysis is only performed on securities with market caps in excess of $100 million and with daily trade volume in excess of $50 million.

Disclaimers

The information in our newsletter is not intended to constitute investment advice and is not designed to meet your personal financial situation. It is provided for information purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor or a group of investors. It should not be assumed that any investments in securities, companies, sectors or markets identified and described will be profitable. We strongly advise you to discuss your investment options with your financial advisor prior to making any investments, including whether any investment is suitable for your specific needs.

Although we obtain information contained in our newsletter from sources we believe to be reliable, we cannot guarantee its accuracy. The analysis provided in this newsletter is based on the prior trading day’s closing prices and may not reflect after-hours trading, earnings announcements, or other significant market events that occur outside regular trading hours. As such, any data or commentary may not fully capture the latest market movements or emerging factors. For the most current and comprehensive view, please consider additional sources or consult with a qualified financial professional.

The information provided in our newsletter is private, privileged, and confidential information, licensed for your sole individual use as a subscriber. We reserve all rights to the content of this newsletter. Forwarding, copying, disseminating, or distributing this newsletter in whole or in part, including substantial quotation of any portion the publication or any release of specific investment recommendations, is strictly prohibited.